RxDoctor Payments Data

Dinesh Chinthagada, MD

Interventional Pain Medicine · Evergreen Park, ILNPI 1699702753

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Abbott at 52.3% of the total. 2025 is the largest year on record at $633, 9.3 times the $68 reported in 2019. That places this record below the midpoint for interventional pain medicine clinicians in IL, where the typical reported total is $2,254.

$2,518in general payments, 2019–2025

Across 70 payments — averaging $35.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Vertos Medical, Inc.$495
  • Boston Scientific$322
  • Nalu Medical, Inc.$132
  • Medtronic$61
  • AstraZeneca$45
  • plus $146 from 5 others

What the payments were for

  • Food & beverage$2,518100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,518 in reported general payments places this provider in the 50th percentile of 93 interventional pain medicine providers in Illinois.

See all interventional pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$53,861
Medicare patients
127
Services billed
663

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen152$4,995
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen151$3,236
Gabapentin116$1,552
Oxycodone Hcl84$1,337
Celecoxib21$1,182
Diclofenac Potassium32$753
Cyclobenzaprine Hcl49$546
Tramadol Hcl56$461
Baclofen16$318
Pregabalin24$301
Meloxicam65$257
Methocarbamol12$212
Diclofenac Sodium11$186
Tizanidine Hcl11$141
Methylprednisolone15$128

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Evergreen Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →